Friday 6 November 2026 Export ALKS’s income statement to Excel — free account

Alkermes plc

ALKS Healthcare Drug Manufacturers Specialty & Generic

Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.

Revenue: +21.8%
EPS: −80.6%
Free cash flow: +6.78%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

45.66 1.12 +2.51%

Follow ALKS

Alert me

Market cap: $7.5B
P/E: 0.0×
Fwd P/E: −85.9×
Dividend yield: —
F-score: 7/9
Altman Z: 5.33
Beneish M: −3.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	0.00	130.02	38.02	19.03	+8 more quarters Free account
P/S ratio Full definition →	3.88	5.25	3.76	3.12
P/FCF ratio Full definition →	29.78	39.30	26.57	9.57
P/Operating CF Full definition →	72.77	60.28	(35.46)	27.10
P/B ratio Full definition →	3.65	4.84	3.36	2.53
Price to Tangible BV Full definition →	0.00	0.00	0.00	2.66
EV/Sales Full definition →	4.30	5.76	4.40	2.42
EV/EBITDA Full definition →	34.72	43.12	28.20	12.73
EV/Operating CF Full definition →	31.05	38.21	26.84	6.87
EV/FCF Full definition →	33.03	43.10	31.08	7.43
Quick Ratio Full definition →	1.86	1.68	1.53	3.04
Current Ratio Full definition →	2.42	2.30	2.27	3.55
Net Debt/EBITDA Full definition →	8.08	10.63	(61.92)	(21.30)
Debt/Assets Full definition →	33.77%	34.22%	35.47%	0.00%
Debt/Equity Full definition →	0.80	0.83	0.86	0.00
Asset Turnover Full definition →	0.52	0.50	0.49	0.65
Operating CF/Net income Full definition →	5.74	289.79	2.49	3.45
Capex/Depreciation Full definition →	(0.06)	(0.13)	(0.13)	0.28
Interest Coverage Full definition →	1.31	0.71	(2.31)	—
Research and Development Expense of Revenue Full definition →	25.23%	22.77%	26.30%	24.19%
Selling, General and Administrative Expense of Revenue Full definition →	43.43%	43.88%	67.34%	48.68%
Intangible Assets out of Total Assets Full definition →	0.53	0.54	0.56	0.03
Share Based Compensation of Revenue Full definition →	5.57%	6.28%	9.25%	6.83%
Graham Net Nets Full definition →	(0.15)	(0.12)	(0.20)	0.27
Graham Number Full definition →	0.00	9.91	14.85	19.11
Earnings Yield Full definition →	0.00%	0.77%	2.63%	5.25%
Free Cash Flow Yield Full definition →	3.36%	2.54%	3.76%	10.45%
Revenue per Share Full definition →	2.86	2.97	2.36	2.33
Operating CF per Share Full definition →	0.56	0.87	(1.00)	1.03
Capex per Share Full definition →	(0.02)	(0.05)	(0.02)	0.01
Free Cash Flow per Share Full definition →	0.54	0.82	(1.02)	1.04
Cash per Share Full definition →	4.50	3.93	3.08	8.01
Shareholders Equity per Share Full definition →	11.11	10.83	10.54	11.05
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	11.11	10.83	10.54	11.05
Free Cash Flow Full definition →	90.08	137.04	(169.82)	171.14
Working Capital Full definition →	928.81	860.82	759.15	1,385.72
Capital Expenditures Full definition →	(3.40)	(8.15)	(4.08)	1.07
Net Current Asset Value Full definition →	(990.06)	(1,061.67)	(1,147.90)	1,261.46
EV/EBIT Full definition →	117.51	81.86	35.83	14.09
Capex to Sales Full definition →	0.01	0.02	0.01	0.00
Price to Operating Income Full definition →	105.95	74.64	30.63	18.15
Other line items
Average Receivables Full definition →	406.74	405.69	363.17	359.28
Average Payables Full definition →	254.71	289.11	239.31	237.45
Average Inventory Full definition →	226.05	245.44	260.07	189.76
Average Assets Full definition →	3,382.52	3,322.97	3,170.03	2,271.28
Average Common Equity Full definition →	1,799.08	1,716.57	1,631.56	1,642.14

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly